Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-27

Clinical Trial Update: The Comparative Effectiveness of Alprostadil,Sodium Ferulate and Dopamine in Pediatric Acute Kidney Injury [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing alprostadil, sodium ferulate, and dopamine for pediatric acute kidney injury is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALPROSTADIL (ALPROSTADIL)
  • Dopamine (dopamine)
  • Sodium ferulate (sodium ferulate)

Snippet

Sponsor: Shengjing Hospital | Conditions: Children AKI Patients | Phase 4 | Status: UNKNOWN